OPKO Health, Inc. (NASDAQ: OPK)
Hagens Berman Sobol Shapiro LLP alerts investors in OPKO Health, Inc. (NASDAQ: OPK) to the firm's investigation into possible securities law violations.
If you purchased or otherwise acquired securities of OPK before September 7, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing OPK@hbsslaw.com.
On September 7, 2018, the U.S. Securities and Exchange Commission sued, among others, OPKO and its founder and CEO (Phillip Frost), alleging they participated in unlawful “pump-and-dump” schemes in the stock of three public companies from 2013 through 2018.
This news drove the price of OPKO shares down $1.01, or about 18%, that day.
“We’re focused on investors’ losses and on management’s earlier statements about the sustainability of OPKO’s business model that, if inaccurate, may have misled investors,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding OPKO should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email OPK@hbsslaw.com.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.